Please assess the completion status of the following clinical trial:

Trial Title: Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Major depression~Exclusion Criteria:~* Allergy towards pindolol, venlafaxine or other tablet constituents~* Liver or kidney impairment~* Diabetics~* Age below 18 years~* Severe cardiac disease~* Asthma.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Venlafaxine and pindolol
- B (Type: PLACEBO_COMPARATOR): Venlafaxin and placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).